Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma

Digestive Diseases and Sciences

Volumn 45, Issue 12, 2000, Pages 2367-2368

  Green, Jesse A ^a,b   Amaro, Rafael ^a,b   Barkin, Jamie S ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Slocum Dickson Medical Group   (United States)

Author keywords

Adenocarcinoma; Gastroesophageal reflux

Indexed keywords

ADENOCARCINOMA; CANCER RISK; CASE CONTROL STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; GASTROESOPHAGEAL REFLUX; HUMAN; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CARDIA; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; HUMANS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0034465576     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005638924929     Document Type: Review

References (13)

1. Symptomatic gastroesophageal reflux: Incidence and precipitating factors
2. Adenocarcinoma of the esophagus and gastric cardia: Is there progress in the face of increasing cancer incidence?
3. Prognosis of adenocarcinoma arising in Barrett's esophagus
4. Barrett's esophagus
5. Symptomatic gastro esophageal reflux as a risk factor for esophageal adenocarcinoma
6. Barrett's esophagus: Functional assessment, proposed pathogenesis and surgical therapy
7. GEORGE Consortium: Risk factors for Barrett's esophagus in community-based practice
8. Endoscopic surveillance of Barrett's esophagus: Does it help?
9. Heartburn - A serious symptom
10. Regression of columnar lined (Barrett's oesophagus) with continuous omeprazole therapy
11. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole
12. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and non-surveyed patients
13. Endoscopic surveillance in Barrett's esophagus. Does it help?